T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

BACKGROUND: Chimeric antigen receptor (CAR) modified T cells targeting CD19 have shown activity in case series of patients with acute and chronic lymphocytic leukaemia and B-cell lymphomas, but feasibility, toxicity, and response rates of consecutively enrolled patients treated with a consistent reg...

全面介紹

Na minha lista:
書目詳細資料
發表在:Lancet
Main Authors: Lee, Daniel W, Kochenderfer, James N, Stetler-Stevenson, Maryalice, Cui, Yongzhi K, Delbrook, Cindy, Feldman, Steven A, Fry, Terry J, Orentas, Rimas, Sabatino, Marianna, Shah, Nirali N, Steinberg, Seth M, Stroncek, Dave, Tschernia, Nick, Yuan, Constance, Zhang, Hua, Zhang, Ling, Rosenberg, Steven A, Wayne, Alan S, Mackall, Crystal L
格式: Artigo
語言:Inglês
出版: 2014
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065359/
https://ncbi.nlm.nih.gov/pubmed/25319501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(14)61403-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍